Overview
Fly-Gen is a biotechnology spin-off working on natural active compounds, drug discovery, protein design and analysis of natural products for regenerative medicine. It develops scientific software and in silico models, designs antibacterial peptides and recombinant enzymes targeting dead tissue in non-healing wounds, and offers chemical synthesis, protein and enzyme optimization, drug delivery systems, and sample analysis.
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 226 days for 2022).
- 202530/06/2026
- 202414/08/2025
- 202303/06/2024
- 202226/02/2024
- 202109/01/2023
- 202031/03/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Artur Wiktor Góraage 52 | 23 | $310.64 | 23% |
Anna Elżbieta Kasprzyckaage 51 | 23 | $310.64 | 23% |
Tomasz Leon Magdziarz | 23 | $310.64 | 23% |
Tomasz Waldemar Skalskiage 59 | 23 | $310.64 | 23% |
Others | 8 | $108.05 | 8% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-04-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 25, 2024 | Aid for research and development projects: industrial research | $187.8K$187,805 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sfpesp. z o.o. | $72,850.26 | sfpe.co.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Receptonsp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| Biostat Research and Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Orphinic ScientificS.A. | $42,972.42 | orphinic.com | ||
| Target Cellssp. z o.o. | $41,315.36 | targetcells.pl | ||
| Pioligonsp. z o.o. | $29,597.16 | pioligon.pl | ||
| Data2biologysp. z o.o. | $28,567.58 | data2biology.com | ||
| InventroS.A. | $25,971.59 | inventro.co | ||
| Cellissp. z o.o. | $24,935.59 | cellis.eu |
FAQ
Last updated: 2026-07-06